Overexpression of GLUT1 in colorectal cancer is independently associated with poor prognosis

International Journal of Biological Markers

Volumn 26, Issue 3, 2011, Pages 166-172

  Shen, Yang Mei ^a,b   Arbman, Gunnar ^c   Olsson, Birgit ^a   Sun, Xiao Feng ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b SICHUAN UNIVERSITY   (China)

^c VRINNEVI HOSPITAL   (Sweden)

Author keywords

Colorectal cancer; GLUT1; Prognosis; Real time PCR

Indexed keywords

GLUCOSE TRANSPORTER 1; SLC2A1 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; ADVANCED CANCER; AGED; ARTICLE; COLORECTAL CANCER; EARLY CANCER; FEMALE; GENE OVEREXPRESSION; GENETIC ASSOCIATION; HUMAN; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; TUMOR DIFFERENTIATION; TUMOR VOLUME; BIOSYNTHESIS; COLORECTAL TUMOR; GENETICS; METABOLISM; PATHOLOGY; PROCEDURES;

AGED; BIOMARKERS, TUMOR; COLORECTAL NEOPLASMS; FEMALE; GLUCOSE TRANSPORTER TYPE 1; HUMANS; MALE; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 80053381472     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.5301/JBM.2011.8550     Document Type: Article

References (34)

1. Stewart BW, Kleihues P, eds. World cancer report. Lyon: IARC Press, 2003.
2. Cancerfonden, The Swedish Cancer Society. Annual Report 2008 (Cancerfondsrapporten 2008). Available at http://www.cancerfonden.se.
3. DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: principles and practice of oncology. Philadelphia: Lippincott Williams and Wilkins, 2004.
4. Coleman CN: Modulating the radiation response. Stem Cells 1996; 14: 10-5.
5. Trédan O, Galmarini CM, Patel K, Tannock IF: Drug resistance and the solid tumor microenvironment. J Natl Cancer Inst 2007; 99: 1441-54.
6. Maher F, Vannucci SJ, Simpson IA. Glucose transporter proteins in brain. FASEB J 1994; 8: 1003-11.
7. Camps M, Vilaro S, Testar X, Palacin M, Zorzano A. Hig and polarized expression of GLUTI glucose transporters in epitheial cells from mammary gland: acute down-regulation of GLUT1 carriers by weaning. Endocrinology 1994; 134: 924-34.
8. Jansson T, Wennergren M, Illsley NP. Glucose transporter protein expression in human placenta throughout gestation and in intrauterine growth retardation. J Clin Endocrinol Metab 1993; 77: 1554-62.
9. Younes M, Lechago LV, Lechago J. Overexpression of the human erythrocyte glucose transporter occurs as a late event in human colorectal carcinogenesis and is associated with an increased incidence of lymph node metastases. Clin Cancer Res 1996; 2: 1151-4.
10. Haber RS, Rathan A, Weiser KR, et al. GLUT1 glucosetransporter expression in colorectal carcinoma: a marker for poor prognosis. Cancer 1998; 83: 34-40.
11. Younes M, Lechago LV, Somoano JR, Mosharaf M, Lechago J. Wide expression of the human erythrocyte glucose transporter Glut1 in human cancers. Cancer Res 1996; 56: 1164-7.
12. Younes M, Brown RW, Stephenson M, Gondo M, Cagle PT. Overexpression of Glut1 and Glut3 in stage I nonsmall cell lung carcinoma is associated with poor survival. Cancer 1997; 80: 1046-51.
13. Airley RE, Mobasheri A. Hypoxic regulation of glucose transport, anaerobic metabolism and angiogenesis in cancer: novel pathways and targets for anticancer therapeutics. Chemotherapy 2007; 53: 233-56.
14. Medina RA, Owen GI. Glucose transporters: expression, regulation and cancer. Biol Res 2002; 35: 9-26.
15. Cooper R, Sarioǧlu S, Sökmen S, et al. Glucose transporter-1 (GLUT-1): a potential marker of prognosis in rectalcarcinoma? Br J Cancer 2003; 89: 870-6.
16. Airley R, Loncaster J, Davidson S, et al. Glucose transporter Glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix. Clin Cancer Res 2001; 7: 928-34.
17. Winter SC, Buffa FM, Silva P, et al. Relation of a hypoxia metagene derived from head and neck cancer to prognosis of multiple cancers. Cancer Res 2007; 67: 3441-9.
18. Jans J, van Dijk JH, van Schelven S, et al. Expression and localization of hypoxia proteins in prostate cancer: prognostic implications after radical prostatectomy. Urology 2010; 75: 786-92.
19. Zhang H, Nordenskjöld B, Dufmats M, Söderkvist P, Sun XF. K-ras mutations in colorectal adenocarcinomas and neighbouring transitional mucosa. Eur J Cancer 1998; 34: 2053-7.
20. Nakamura Y, Nawata M, Wakitani S. Expression profiles and functional analyses of Wnt-related genes in human joint disorders. Am J Pathol 2005; 167: 97-105.
21. Mori M, Staniunas RJ, Barnard GF, Jessup JM, Steele GD Jr, Chen LB. The significance of carbonic anhydrase expression in human colorectal cancer. Gastroenterology 1993; 105: 820-6.
22. Warburg O. On the origin of cancer cells. Science 1956; 123: 309-14.
23. Hatanaka M. Transport of sugars in tumor membranes. Biochem Biophys Acta 1974; 355: 77-104.
24. Brown RS, Wahl RL. Overexpression of Glut-1 glucose transporter in human breast cancer.An immunohistochemical study. Cancer 1993; 72: 2979-85.
25. Mellanen P, Minn H, Grénman R, Härkönen P. Expression of glucose transporters in head-and-neck tumors. Int J Cancer 56: 622-9, 1994.
26. Ito T, Noguchi Y, Satoh S, Hayashi H, Inayama Y, Kitamura H. Expression of facilitative glucose transporter isoforms in lung carcinomas: its relation to histologic type, differentiation grade, and tumor stage. Mod Pathol 1998; 11: 437-43.
27. Yamamoto T, Seino Y, Fukumoto H, et al. Over-expression of facilitative glucose transporter genes in human cancer. Biochem Biophys Res Commun 1990; 170: 223-30.
28. Chung FY, Huang MY, Yeh CS, et al. GLUT1 gene is apotential hypoxic marker in colorectal cancer patients. BMC Cancer 2009; 9: 241.
29. Van Laarhoven HW, Kaanders JH, Lok J, et al. Hypoxia in relation to vasculature and proliferation in liver metastases in patients with colorectal cancer. Int J Radiat Oncol Biol Phys 2006; 64: 473-82.
30. Bos JL. Ras oncogenes in human cancer: a review. Cancer Res 1989; 49: 4682-9.
31. Davies H, Bignell GR, Cox C, et al. Mutations of the BRAF gene in human cancer. Nature 2002; 417: 949-54.
32. Rajagopalan H, Bardelli A, Lengauer C, Kinzler KW, Vogelstein B, Velculescu VE. Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status. Nature 2002; 418: 934.
33. Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nat Med 2004; 10: 789-99.
34. Yun J, Rago C, Cheong I, et al. Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells. Science 2009; 325: 1555-9.